Quantitative EEG

Unlock the potential of advanced analysis techniques to gain deeper insights into brain activity.

BEAM™: A Leader in Innovative Brain Health Approaches

BEAM™ sets personalized brain health care standards by seamlessly integrating EEG with automated neurocognitive tests to compute biomarkers. This advanced biomarker technology, combined with in-depth analytics, not only provides a detailed understanding of neurodegenerative and psychiatric conditions but also assists in differentiating dementia sub-types, quantifying the severity of cognitive decline, tracking disease progression, and assessing treatment efficacy. This comprehensive approach positions BEAM™ at the forefront of brain health innovation, offering precise and personalized medical solutions for the brain.

BEAM™ Biomarkers & Analytics

Neurodegenerative Focus

Targeting Mild Cognitive Impairment, Alzheimer’s, Lewy Body, Parkinson’s, Huntington’s.

Psychiatric Assessment

Addressing Depression, Anxiety, PTSD.

Advanced Technology

Combining EEG with automated neurocognitive tests, referencing an extensive normative database.

Precision Diagnostics

Assisting in differentiating dementia subtypes, quantifying cognitive decline, tracking progression, and assessing treatment efficacy.

Key Features of BEAM™

Proven & Objective

Reliable analytics for precise diagnosis.

Early Detection

Highly sensitive for early-stage identification.

Non-Invasive & Convenient

A straightforward alternative to MRI/PET.


Significantly less expensive than conventional imaging.

Regular Monitoring

Ideal for ongoing brain health assessments.


Transforming Diagnosis


64-year-old diagnosed with amnestic MCI.


Despite normal MMSE scores, BEAM™ biosignature analysis revealed a shift from healthy to MCI, underscoring the sensitivity of our system.

Technology and Compliance

AI-Driven Analysis

Machine learning algorithms for biosignature classification, disease severity quantification, and treatment efficacy assessment

FDA Cleared & HIPAA Compliant

Providing exceptional reliability and stringent data security.

Drug Response Biomarkers

Validated for anxiolytics, antidepressants, and psychedelics.

Empowering Healthcare Providers

Rapid Deployment & Training

Easy-to-use system, quick setup, and 4-hour on-site technician training.

Objective Cognitive Assessment

Thorough evaluation of central and autonomic nervous systems, crucial for accurate clinical decision-making.

The BEAM™ System

21-Channel EEG System: In-depth neurophysiological patient assessments.

Clear, Actionable Reports: Understandable and actionable test results.

Versatile Biomarker Detection: Effective for a wide range of conditions, including dementia, TBI, ADHD, and PTSD.

Revolutionizing Neurocognitive Healthcare with BEAM™

Discover how BEAM™’s integrated system is reshaping the approach to brain health monitoring and care, from healthy aging to managing neurodegenerative decline.

Get Started Now

Neurovative Diagnostics accepts referrals from thousands of hospitals, facilities, physicians, and private practices across the country.